
Rejuve Biotech is a biotechnology company focused on developing therapeutics for longevity and age-associated diseases using AI. They differentiate themselves by integrating data from long-lived animal models, specifically the Methuselah Fly, with crowdsourced human data. Their proprietary neural-symbolic AI and systems-biology aging model enable rapid development of healthspan-enhancing and disease-mitigating products. The company's approach shortens the drug discovery pipeline by analyzing cross-organism data, and they have demonstrated proof of concept with a supplement that preserved cognitive function in Alzheimer's patients. Rejuve Biotech's business model includes licensing their methods and techniques to other biotech projects.

Rejuve Biotech is a biotechnology company focused on developing therapeutics for longevity and age-associated diseases using AI. They differentiate themselves by integrating data from long-lived animal models, specifically the Methuselah Fly, with crowdsourced human data. Their proprietary neural-symbolic AI and systems-biology aging model enable rapid development of healthspan-enhancing and disease-mitigating products. The company's approach shortens the drug discovery pipeline by analyzing cross-organism data, and they have demonstrated proof of concept with a supplement that preserved cognitive function in Alzheimer's patients. Rejuve Biotech's business model includes licensing their methods and techniques to other biotech projects.